Your new post is loading...
A study showing that vasoactive intestinal peptide (VIP) is able to reduce the pathogenic profile of Th17 cells and favoring Treg cell differentiation.
|
Scooped by Alfredo Corell |
Scoop.it!
No comment yet.
Sign up to comment
These results indicate that VIP may have promising effects in the early phase of RA targeting the inhibition of pathogenic Th17 cells,and favoring Treg cell differentiation.
Source: Journal of Leukocyte Biology, 2015. DOI: 10.1189/jlb.3A0714-327R
Read more: Journal of Leukocyte Biology
See also: IL-17: A Promising Therapeutic Target in Several Chronic Inflammatory Diseases
Important New Features and Glucocorticoid-Resistance of Pro-Inflammatory Th17 Cells